Trial · NCT07897747
AI Smart Glasses Feedback for Intubation Training in Medical Students
NCT07897747, Not applicable, Not yet recruiting, Tri-Service General Hospital (TSGH)
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. AI Smart Glasses Feedback for Intubation Training in Medical Students. Trials, record NCT07897747. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07897747
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- AI Smart Glasses Feedback for Intubation Training in Medical Students
- NCT number
- NCT07897747
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 200 participants, estimated
- Lead sponsor
- Tri-Service General Hospital (TSGH)
- Conditions
- Intubation, Intratracheal, Medical Education
- Interventions
- AI smart-glasses intubation practice with automated feedback
- First posted
- 2026-10-27
- Last updated
- 2026-11-06
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Agreement Between AI and Faculty Examiner Total Scores on the Intubation OSCE | End of the 2-week anesthesiology rotation (Week 2, last day) | Intraclass correlation coefficient ICC(2,1) (two-way random effects, absolute agreement, single rater) with 95% confidence interval between the AI-generated total score and the faculty examiner's total score on the 10-item endotracheal intubation OSCE checklist (each item scored 0, 1, or 2; total score range 0-20, higher scores indicate better performance). Bland-Altman mean difference and 95% limits of agreement will also be reported. The faculty examiner is blinded to group allocation and to the AI score. |
| Secondary | Faculty-Rated Intubation OSCE Total Score | End of the 2-week anesthesiology rotation (Week 2, last day) | Total score on the 10-item endotracheal intubation OSCE checklist rated by a faculty examiner blinded to group allocation (each item 0, 1, or 2; range 0-20; higher scores indicate better performance), compared between arms. |
| Secondary | Faculty-Rated Global Performance Rating on the Intubation OSCE | End of the 2-week anesthesiology rotation (Week 2, last day) | Faculty examiner's global rating of intubation performance on a 5-point scale (1 = poor, 2 = needs improvement, 3 = fair, 4 = good, 5 = excellent; higher scores indicate better performance), compared between arms. |
| Secondary | Intubation OSCE Pass Rate | End of the 2-week anesthesiology rotation (Week 2, last day) | Percentage of participants judged by the faculty examiner to pass the intubation OSCE according to the national graduation competency standard (correct laryngoscope use, correct and appropriate tube placement, and completion of one tube placement within 30 seconds), compared between arms. |
| Secondary | Intubation Time | End of the 2-week anesthesiology rotation (Week 2, last day) | Time in seconds from insertion of the laryngoscope blade into the mouth to completion of endotracheal tube placement and removal of the laryngoscope, timed by the faculty examiner during the OSCE, compared between arms. |
| Secondary | Item-Level and Pass/Fail Agreement Between AI and Faculty Examiner | End of the 2-week anesthesiology rotation (Week 2, last day) | Agreement between AI and faculty examiner for each of the 10 OSCE checklist items (0/1/2) assessed with quadratic weighted kappa, and for the global rating (scored 1 to 5) assessed with ICC(2,1); agreement on pass/fail assessed with Cohen's kappa, with sensitivity and specificity of the AI pass/fail judgment using the faculty judgment as the reference standard. |
| Secondary | Change in Intubation-Specific Self-Efficacy Score | Baseline (Week 1, Day 1) and end of the 2-week rotation (Week 2, last day, after the OSCE) | Mean score of a 4-item intubation self-efficacy scale adapted from a published smart-glasses intubation training study, each item rated on a 5-point scale (1 = not at all confident, 5 = very confident; range 1-5; higher scores indicate greater self-efficacy). Change from baseline to end of rotation is compared between arms. |
| Secondary | Change in Medical Learning Self-Efficacy Score | Baseline (Week 1, Day 1) and end of the 2-week rotation (Week 2, last day, after the OSCE) | Mean score of a 39-item medical learning self-efficacy questionnaire adapted from a validated multi-dimensional medical students' learning self-efficacy questionnaire (subscales: conceptual understanding, practical work, everyday application, higher-order cognitive skills, medical communication, professionalism, and academic self-efficacy), each item rated on a 5-point Likert scale (1 = strongly disagree, 5 = strongly agree; range 1-5; higher scores indicate greater self-efficacy). Change from baseline to end of rotation is compared between arms. |
| Secondary | Cognitive Load During AI Smart-Glasses Practice | Immediately after the AI smart-glasses practice session (Week 1, Days 2-4 in Arm 1; Week 2, Days 1-4 in Arm 2) | Intrinsic (items 1-3), extraneous (items 4-6), and germane (items 7-10) cognitive load subscale mean scores on a validated 10-item cognitive load questionnaire, each item rated on a 5-point scale (1 = not at all applicable, 5 = completely applicable; range 1-5). Higher intrinsic and extraneous scores indicate greater load; higher germane scores indicate greater investment in learning. Compared between arms. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers3
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07897747
GET https://conductscience.org/api/trials/v1/NCT07897747/registered